IL-17 is Aberrantly Overexpressed Among Under-treatment Systemic Lupus Erythematosus Patients

BACKGROUND & OBJECTIVE: Systemic lupus erythematosus (SLE) is an autoimmune disease with chronic inflammatory immune response. Current therapies mostly rely on glucocorticoids which are accompanied by side-effects and mostly fail to achieve a favorable remission. Th17 subpopulation of T cells is...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammadi, Saeed, Sedighi, Sima, Memarian, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iranian Society of Pathology 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6742740/
https://www.ncbi.nlm.nih.gov/pubmed/31583001
http://dx.doi.org/10.30699/ijp.2019.94878.1934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6742740/
https://www.ncbi.nlm.nih.gov/pubmed/31583001
http://dx.doi.org/10.30699/ijp.2019.94878.1934

Ejemplares similares